Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Samuel J. Vodovoz"'
Autor:
Yinghua Jiang, Jinrui Han, Pierce Spencer, Yadan Li, Samuel J. Vodovoz, Ming-Ming Ning, Ning Liu, Xiaoying Wang, Aaron S. Dumont
Publikováno v:
Brain Hemorrhages, Vol 2, Iss 3, Pp 116-123 (2021)
Intravenous tissue type plasminogen activator thrombolytic therapy has long been a mainstay in acute ischemic stroke therapy. However, patients receiving IV tPA therapy may have variable response with some subsets of patients having worsened outcomes
Externí odkaz:
https://doaj.org/article/e3a16ba095dc4754ae4514af9b6925e7
Autor:
Samuel X. Shi, Samuel J. Vodovoz, Yuwen Xiu, Ning Liu, Yinghua Jiang, Prasad V. G. Katakam, Gregory Bix, Aaron S. Dumont, Xiaoying Wang
Publikováno v:
Cells, Vol 11, Iss 13, p 2011 (2022)
In the pathophysiology of hemorrhagic stroke, the perturbation of the neurovascular unit (NVU), a functional group of the microvascular and brain intrinsic cellular components, is implicated in the progression of secondary injury and partially inform
Externí odkaz:
https://doaj.org/article/eb7e2f0c69244715b73d23b1e178f6af
Autor:
Yadan Li, MingMing Ning, Pierce Spencer, Xiaoying Wang, Jinrui Han, Samuel J. Vodovoz, Yinghua Jiang, Ning Liu, Aaron S. Dumont
Publikováno v:
Brain Hemorrhages, Vol 2, Iss 3, Pp 116-123 (2021)
Intravenous tissue type plasminogen activator thrombolytic therapy has long been a mainstay in acute ischemic stroke therapy. However, patients receiving IV tPA therapy may have variable response with some subsets of patients having worsened outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0250e351e9f8a704754d4461d30d3d41
http://www.sciencedirect.com/science/article/pii/S2589238X20300656
http://www.sciencedirect.com/science/article/pii/S2589238X20300656
Autor:
Samuel X Shi, Boli Zhang, Mardeen S. Karim, Yinghua Jiang, Ning Liu, Xiaoying Wang, Min Zhou, Samuel J. Vodovoz, Aaron S. Dumont
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 3795, p 3795 (2021)
Journal of Clinical Medicine
Journal of Clinical Medicine
Blood-brain barrier (BBB) disruption following ischemic stroke (IS) contributes to hemorrhagic transformation, brain edema, increased neural dysfunction, secondary injury, and mortality. Brain endothelial cells form a para and transcellular barrier t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f8de713f40952155b9389b520058491
https://www.mdpi.com/2077-0383/10/17/3795
https://www.mdpi.com/2077-0383/10/17/3795
Autor:
Xiaoying Wang, Yinghua Jiang, Aaron S. Dumont, Yadan Li, Jinrui Han, Ning Liu, Pierce Spencer, Samuel J. Vodovoz
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 100, p 100 (2021)
Journal of Clinical Medicine, Vol 10, Iss 100, p 100 (2021)
Cerebral metabolic dysfunction has been shown to extensively mediate the pathophysiology of brain injury after subarachnoid hemorrhage (SAH). The characterization of the alterations of metabolites in the brain can help elucidate pathophysiological ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2430455bb5ae71d77c3667db9b96b5b7
https://pubmed.ncbi.nlm.nih.gov/33396652
https://pubmed.ncbi.nlm.nih.gov/33396652
Diabetes Mellitus/Poststroke Hyperglycemia: a Detrimental Factor for tPA Thrombolytic Stroke Therapy
Autor:
Aaron S. Dumont, Pierce Spencer, Yadan Li, Yinghua Jiang, Jinrui Han, Samuel J. Vodovoz, Prasad V. G. Katakam, Ning Liu, Xiaoying Wang, Gregory J. Bix, MingMing Ning
Publikováno v:
Translational stroke research. 12(3)
Intravenous administration of tissue-type plasminogen activator (IV tPA) therapy has long been considered a mainstay in ischemic stroke management. However, patients respond to IV tPA therapy unequally with some subsets of patients having worsened ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf8529cac14ed5b7e01f11f223ec18c6
https://pubmed.ncbi.nlm.nih.gov/33140258
https://pubmed.ncbi.nlm.nih.gov/33140258